About              FAQs              Join             Internship  

A close-up of a healthcare professional's hands wearing blue gloves, holding a syringe and an insulin vial, with a warm light in the background.

Opinion: America’s deadly flaw – the cost of life-saving drugs

No one should have to choose between their life and their livelihood—it's time to demand affordable, life-saving medications for all.
<a href="https://highschool.latimes.com/author/jaiyenshetty/" target="_self">Jaiyen Shetty</a>

Jaiyen Shetty

August 19, 2024

The vial slipped from my trembling fingers, shattering on the cold tile floor. A pool of clear liquid spread slowly, each drop worth more than its weight in gold. My heart raced as I stared at the spilled insulin—three hundred dollars gone in an instant. But it wasn’t just money seeping into the cracks; it was my lifeline, my future, my very existence.

This moment of clumsiness could have been a mere inconvenience. Instead, it became a life-threatening crisis. Welcome to America, where a simple mistake can spiral into a fight for survival, all because of the exorbitant cost of life-saving drugs.

I’m just one of the millions of Americans caught in this deadly game of financial Russian roulette. According to the American Diabetes Association, the average price of insulin nearly tripled between 2002 and 2013. This isn’t just a statistic; it’s a life-threatening reality for people like me and countless others dependent on various medications. From EpiPens to cancer treatments, life-saving drugs in America have become a luxury many can’t afford.

The question we need to ask ourselves is: how much are we willing to sacrifice in order to stay alive?

The Economics of Survival

In this high-stakes game of life, we’re not dodging fictional obstacles; we’re dodging bankruptcy. The Centers for Disease Control and Prevention reports that 3 in 10 Americans ration their medications due to cost. This isn’t just alarming; it’s a national disgrace.

Take insulin, for example. A vial that costs $3 to produce is sold for nearly $300 in the U.S. In other developed countries, the same vial costs a fraction of this price. This isn’t innovation; it’s exploitation on a massive scale. The difference in pricing is not due to quality or effectiveness but rather the result of a broken system that prioritizes profits over people.

The Human Cost

Behind these staggering numbers are real people making impossible choices. A 2019 study in the Journal of the American Medical Association found that 1 in 4 patients with diabetes rationed their insulin due to cost. This isn’t just risky; it’s potentially fatal.

I’ve witnessed families torn apart by these impossible decisions. Parents skipping meals to afford their child’s medication. Elderly couples splitting pills to make prescriptions last longer. Young adults choosing between paying rent or staying alive. This isn’t the America we were promised. When the basic act of staying alive becomes a luxury, something is fundamentally wrong with our system.

Consider the story of Alec Raeshawn Smith, a young man who died because he could not afford his insulin after aging out of his parents’ insurance plan. His mother, Nicole Smith-Holt, has since become an advocate for affordable insulin, but her son’s life is a price no family should have to pay. Alec’s story is not an isolated incident. It’s a tragic example of what happens when healthcare becomes a commodity rather than a right.

The Monopoly Game

So why are these drugs so expensive? The pharmaceutical industry often argues that high prices are necessary for innovation. However, a 2016 study published in the Journal of the American Medical Association found no significant association between research and development costs and drug prices. Instead, we’re seeing a monopoly game played with people’s lives. Patent laws and lack of price regulations allow companies to set prices at will. It’s not the invisible hand of the market; it’s the very visible hand of corporate greed.

Monopolies thrive in this environment. For instance, the patent system is designed to encourage innovation by giving companies exclusive rights to their discoveries for a limited time. But in reality, these patents are often extended through minor modifications to the drug, a practice known as “evergreening.” This prevents generic alternatives from entering the market and keeps prices artificially high. Meanwhile, patients are left with few options and even fewer financial resources.

The Global Comparison

The U.S. is an outlier when it comes to drug pricing. In countries like Canada and the United Kingdom, governments negotiate drug prices on behalf of their citizens. The result? Canadians pay approximately one-tenth the price for insulin compared to Americans. In the UK, the National Health Service (NHS) provides medications like insulin at no cost to the patient. These countries have found a way to balance innovation with affordability, proving that it’s possible to do both.

The difference in outcomes is stark. While Americans are forced to make life-or-death decisions based on their bank accounts, citizens in other developed nations receive the medications they need without the burden of crippling debt. This isn’t just a matter of policy—it’s a matter of values. It’s time we asked ourselves what kind of country we want to be. Do we value profits over people, or are we willing to stand up for the basic human right to health?

A Glimmer of Hope

But there’s hope. In the U.S., recent legislative efforts like the Inflation Reduction Act are steps in the right direction, allowing Medicare to negotiate some drug prices. However, these changes will only cover a small percentage of drugs and won’t take full effect until 2026. We need to go further, much further.

Technology also offers some solutions. Innovative apps and platforms are emerging to help patients manage their conditions more effectively and find more affordable options. For example, GoodRx allows users to compare prices and find discounts at local pharmacies, providing a lifeline for those struggling to afford their medications. However, technology alone isn’t enough. We need systemic change.

Organizations like T1International are fighting for affordable insulin worldwide. Their #insulin4all campaign has already led to policy changes in several states. These grassroots movements show that collective action can make a difference. They remind us that we are not powerless in this fight. Together, we can push for the changes that are so desperately needed.

A Call to Action

As a high school student who’s experienced this crisis firsthand, I urge you to get involved. Contact your representatives. Support organizations fighting for affordable healthcare. Spread awareness about this issue. We can create a future where no one has to ration their medication or go bankrupt to stay alive. A future where the cost of drugs doesn’t overshadow the value of human life.

In America, the land of the free, we shouldn’t be held hostage by the price of staying alive. It’s time we changed the game. Our lives depend on it.

Negative effects of excessive screen time

Negative effects of excessive screen time

In today’s fast-paced world, screens have become an integral part of daily life, serving as a primary means for work, communication, education, and entertainment. Devices such as smartphones, tablets, phones, and computers simplify many tasks, and children are...

The NBA’s “flopping” dilemma

The NBA’s “flopping” dilemma

In the National Basketball Association (NBA) today, flopping, the act of exaggerating contact to draw fouls, remains one of the league’s most debated issues. Under current NBA organization rules, an official can assess a non‑unsportsmanlike technical foul on a player...

Discover more from HS Insider

Subscribe now to keep reading and get access to the full archive.

Continue reading